国药现代(600420.SH)：控股子公司国药致君坪山与安徽美来签署《药品上市许可转让合同》

Core Viewpoint - China National Pharmaceutical Group Modern (国药现代) has signed a drug listing license transfer agreement with Anhui Meilai, aiming to enhance its product pipeline and implement its mid-to-long-term development strategy [1] Group 1 - The agreement involves the transfer of the drug listing license for Lactulose Oral Solution (15ml:10g) from Anhui Meilai to China National Pharmaceutical Group Modern's subsidiary, Guoyao Zhijun Ping Shan [1] - The total transfer fee for the drug listing license is RMB 5.86 million [1]